Results 151 to 160 of about 28,958 (244)

Changes in the use of vitamin K antagonists and direct oral anticoagulants and impact on the incidence of oral anticoagulation-related intracerebral hemorrhage: population-wide prescription patterns in two 5-year cohorts. [PDF]

Ann Med
Tomppo L, Sallinen H, Lankinen O, Mastoras G, Georgiopoulos G, Poli S, Putaala J, Strbian D.   +7 more
europepmc   +1 more source

Safety and Efficacy of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Cerebrovascular Ischemic Outcomes in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis. [PDF]

Clin Cardiol
Nasir A, Anwar N, Kamran AB, Muhammad A, Haider A, Mubashar M, Tariq F, Helou M, Shami B.   +8 more
europepmc   +1 more source

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

Circulation, 2011
J. Eikelboom, L. Wallentin, Stuart J. Connolly, M. Ezekowitz, Jeff S. Healey, Jonas Oldgren, Sean Yang, M. Alings, Scott Kaatz, S. Hohnloser, Hans-Christoph Diener, M. Franzosi, Kurt Huber, P. Reilly, Jeanne Varrone, Salim Yusuf   +15 more
semanticscholar   +1 more source

Hemorrhagic risk of concomitant direct oral anticoagulants and fluoroquinolones: integration of pharmacovigilance and therapeutic drug monitoring. [PDF]

Front Pharmacol
Xu J, Li YD, Han JP, Duan CY, Zhao FL, Shang ZY, Zhu Z, Hu ZH.   +7 more
europepmc   +1 more source

Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation With Advanced Chronic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Metwaly AS, Alqurain AA, Alghanim FF, Alghamdi NA, Alsudairi RK, Dayl AY, Alghamdi BS, Niazi OH, Alfaraj FM, Alsharif NQ, Alfaifi AY, Alzahrani MA, Abdulmgid TH, Alkaf ZA.   +13 more
europepmc   +1 more source

Efficacy and safety of direct oral anticoagulants in pediatric congenital and acquired heart disease: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Thromb J
Bakry HE, Abdellah MI, Khalaf HA, Assem AA, ElGamal MM, Abdo MI, Elkasaby MH, Hassan AA.   +7 more
europepmc   +1 more source

Author response to Zupan et al., Letter to the editor regarding "Intracranial hemorrhage after ischemic stroke in patients on direct oral anticoagulants: results from a prospective observational study" by Purrucker et al. [PDF]

Neurol Res Pract
Purrucker J, Haas K, Sieber M, Rücker V, Heuschmann PU, Veltkamp R.   +5 more
europepmc   +1 more source

Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.

JAMA Internal Medicine, 2016
D. Graham, M. Reichman, M. Wernecke, Ya-Hui Hsueh, R. Izem, M. Southworth, Yuqin Wei, Jiemin Liao, M. Goulding, Katrina Mott, Y. Chillarige, T. MaCurdy, C. Worrall, J. Kelman   +13 more
semanticscholar   +1 more source

Clinical Evaluation of Drug-Drug Interactions With Aficamten. [PDF]

Clin Transl Sci
Maharao N, Xu D, Divanji P, Simkins TJ, Li J, Dumitrescu C, Solanki P, Griffith A, Heitner SB, Kupfer S, German P, Lutz JD.   +11 more
europepmc   +1 more source